12.14
-0.17(-1.38%)
Currency In USD
| Previous Close | 12.31 |
| Open | 12.24 |
| Day High | 12.33 |
| Day Low | 12.01 |
| 52-Week High | 12.91 |
| 52-Week Low | 5.79 |
| Volume | 1.59M |
| Average Volume | 2.37M |
| Market Cap | 2.11B |
| PE | -9.63 |
| EPS | -1.26 |
| Moving Average 50 Days | 10.66 |
| Moving Average 200 Days | 8.78 |
| Change | -0.17 |
If you invested $1000 in Ocular Therapeutix, Inc. (OCUL) 10 years ago, it would be worth $752.17 as of August 20, 2025 at a share price of $12.14. Whereas If you bought $1000 worth of Ocular Therapeutix, Inc. (OCUL) shares 5 years ago, it would be worth $1,419.88 as of August 20, 2025 at a share price of $12.14.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Ocular Therapeutix™ Receives FDA Agreement Under Special Protocol Assessment (SPA) for Registrational Trial of AXPAXLI™ in NPDR
GlobeNewswire Inc.
Aug 12, 2025 11:00 AM GMT
Ocular plans to outline clinical trial design, timing, and development strategy for non-proliferative diabetic retinopathy (NPDR) and diabetic macular edema (DME) at its Investor Day on September 30, 2025BEDFORD, Mass., Aug. 12, 2025 (GLOBE NEWSWIR
Ocular Therapeutix™ to Report Second Quarter 2025 Financial Results on August 5, 2025
GlobeNewswire Inc.
Jul 29, 2025 11:00 AM GMT
BEDFORD, Mass., July 29, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a biopharmaceutical company committed to redefining the retina experience, today announced that it plans to host a conference call and webcast on T
Ocular Therapeutix™ to Participate in Upcoming Scientific Conferences
GlobeNewswire Inc.
Jul 22, 2025 11:00 AM GMT
BEDFORD, Mass., July 22, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a biopharmaceutical company committed to redefining the retina experience, today announced participation in several upcoming scientific conferences